Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cardiff Oncology, Inc. | XE7C | Apr 17, 2025 | 2.42 | -4.73 |
Cardinal Energy Ltd | C0Y | Apr 17, 2025 | 3.84 | +13.60 |
Cardinal Health, Inc. | CLH | Apr 17, 2025 | 118.40 | +0.08 |
Cardiol Therapeutics Inc | CT9 | Apr 17, 2025 | 0.98 | +11.20 |
Cardlytics, Inc. | CYX | Apr 17, 2025 | 1.10 | +9.76 |
CareCloud, Inc. | MTB0 | Apr 17, 2025 | 1.17 | -3.64 |
CareDx, Inc. | 1K9 | Apr 17, 2025 | 16.04 | -2.64 |
Careium AB | I81 | Apr 17, 2025 | 2.49 | -0.80 |
Carel Industries S.p.A. | CIG | Apr 17, 2025 | 16.08 | -0.12 |
CareRx Corporation | 29C1 | Apr 17, 2025 | 1.68 | +1.82 |
CareTrust REIT, Inc. | 7XC | Apr 17, 2025 | 25.20 | +0.80 |
Cargojet Inc | CJ8A | Apr 17, 2025 | 47.80 | -3.24 |
Cargotec | C1C1 | Apr 17, 2025 | 37.60 | +0.16 |
CarGurus, Inc. - Class A | 0C6 | Apr 17, 2025 | 23.60 | 0.00 |
Carisma Therapeutics | W2J | Apr 17, 2025 | 0.17 | -7.58 |
Carl Zeiss Meditec A G | AFXA | Apr 17, 2025 | 57.00 | -3.39 |
Carl Zeiss Meditec A G | AFX | Apr 17, 2025 | 56.30 | -3.43 |
Carlisle Companies Incorporated | CLE | Apr 17, 2025 | 308.30 | -2.37 |
Carlsberg | CBGC | Apr 17, 2025 | 23.60 | +4.42 |
Carlsberg A | CBGA | Apr 17, 2025 | 129.50 | +2.78 |
Carlsberg B | CBGB | Apr 17, 2025 | 119.70 | +5.93 |
Carlson Investments SA | 2HB | Apr 17, 2025 | 0.88 | -1.78 |
Carmat | CXT | Apr 17, 2025 | 0.86 | -5.49 |
CarMax Inc | XA4 | Apr 17, 2025 | 56.50 | -4.20 |
Carmila | CUX1 | Apr 17, 2025 | 17.62 | +3.28 |
Carnarvon Petroleum Ltd. | CJB | Apr 17, 2025 | 0.04 | +2.41 |
Carnavale Resources Limited | YBB | Apr 17, 2025 | 0.00 | 0.00 |
Carnegie Clean Energy Limited | CNM1 | Apr 17, 2025 | 0.02 | +10.98 |
Carnival Corporation | CVC1 | Apr 17, 2025 | 15.87 | -0.50 |
Carnival PLC | POH1 | Apr 17, 2025 | 14.15 | -1.94 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.